News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Secuencia de ADN junto a un reloj para representar la genética aplicada al envejecimiento
Genetics applied to healthy aging becomes a reality with N-GENE
Healthcare
Various studies estimate that genetic factors explain between 20–30% of the variability in lifespan…
Partners - ADNTRO GENETICS SL
Logo de Klinea
Klinea is a B Corp
Corporate
The engineering solutions development company for the pharmaceutical and biotechnology sector is…
Partners - Klinea Biotech & Pharma Engineering
Presentación de los resultados de BIOTRAIM de BIOHOPE en el el World Transplant Congress 2025
Biohope presents the results of the BIOTRAIM study on the use of pretransplant Immunobiogram® at the World Transplant Congress 2025 and they are selected among the most relevant abstracts in kidney transplantation
Healthcare
Immunobiogram® is a test that measures in vitro the sensitivity (response) of each patient's immune…
Partners - Biohope
Banner con los logos de las empresas participantes en el proyecto LUMINA
Flomics Biotech joins Eurostars project LUMINA to advance lung cancer recurrence detection using liquid biopsy and AI
Healthcare
The project, which launched on June 1, 2025, aims to develop an innovative platform for the non-…
Partners - Flomics Biotech
Dos mujeres sonriendo
ORYZON receives European Medicines Agency approval to initiate a Phase Ib study of iadademstat in sickle cell disease
Healthcare · Advanced therapies
First iadademstat clinical trial in non-malignant hematological indications.
Partners - Oryzon Genomics
Un nuevo hito conseguido: se recluta al primer paciente para el ensayo fase III en cirrosis hepática descompensada.
New milestone for Mikrobiomik: recruits first patient in its LiverGut Phase III trial for decompensated liver cirrhosis
Healthcare · Access to innovation
The biotechnology company Mikrobiomik has begun patient recruitment for LiverGut, the first…
Partners - Mikrobiomik
La sede de Oryzon
ORYZON reports financial results and corporate update for half-year ending June 30, 2025
Healthcare
Between December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0…
Partners - Oryzon Genomics
ronda en Capital Cell: Mikrobiomik.
Mikrobiomik launches a Capital Cell funding campaign to support its next clinical trial
Healthcare · Access to innovation
Mikrobiomik launches a Capital Cell funding campaign to support its next clinical trial
Partners - Mikrobiomik
Clesa Innovation Center en Madrid
Kadans presents its new space for innovation in life sciences: Clesa Innovation Center
Healthcare
Located in the heart of biomedical innovation in Madrid, and with an investment of over 35 million…
Partners - KADANS SCIENCE PARTNER 1 SP S.L.